MedPath

Shape Up! Kids Study

Completed
Conditions
Healthy
Registration Number
NCT03706612
Lead Sponsor
University of Hawaii
Brief Summary

Identify the unique associations of body shape to body composition and bone density indices in a pediatric population that represents the variance of sex, age, BMI-Z, and ethnicity found in the US population.

Describe the precision and accuracy of optical scans to monitor change in body composition, bone density and metabolic health interventions.

Estimate the level of association of optical to common health indicators including metabolic risk factors (glucose, triglycerides, HDL-cholesterol, blood pressure, VAT, WC and strength) by gender, race, age, and BMI-Z.

Investigate holistic, high-resolution descriptors of 3D body shape as direct predictors of body composition and metabolic risk using statistical shape models and Latent Class Analysis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
430
Inclusion Criteria
  • Healthy participants will be included in the study if they have a self-reported ability to:

    • walk one-quarter of a mile and climb 10 steps without difficulty,
    • perform activities of daily living (ADLs) without difficulty, and
    • have no life-threatening conditions or diseases that would alter body composition from what is typical for age, sex, ethnicity, and BMI.
Exclusion Criteria
  • any internal metal artifact (e.g. pacemakers, internal fixation, arthroplasty), amputation, physical impairment or previous fracture that would alter body composition assessment
  • Pregnant or breastfeeding. (All premenopausal females will be asked for a spot urine sample for pregnancy test prior to participation. Those unwilling to comply with this will not be included.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fat mass by DXA1 day

Measure fat mass and percent fat (arms, legs, trunk, and total) using Dual energy X-ray absorptiometry (DXA) data

Bone mass by DXA1 day

Measure bone mass (arms, legs, lumbar spine, and total) and Bone Mineral Density (spine and total) using Dual energy X-ray absorptiometry (DXA) data

Automatic 3D optical (3DO) scan measurement1 day

Automated 3DO measurement generated across the body

Fat mass by MRI1 day

Measure fat mass and percent fat (arms, legs, trunk, visceral, and total) using MRI data

Lean mass by MRI1 day

Measure lean mass (arms, legs, trunk, and total) using MRI data

Waist to Hip ratio (WHR) from manual tape measurement1 day

Manual physical anthropometry of waist and hip circumferences

Hand-grip strength1 day

Measured by using a hand-grip dynamometer (JAMAR) as a measure of strength and physical capacity.

Isokinetic peak torque1 day

Measure the peak torque value (FT-LBS) generated during isokinetic knee extension/flexion movement evaluation at 60 degrees will be assessed with the HUMAC NORM device

Lean mass by DXA1 day

Measure lean mass (arms, legs, trunk, and total) using Dual energy X-ray absorptiometry (DXA) data

Isometric peak torque1 day

Measure the peak torque value (FT-LBS) generated during isometric knee extension/flexion movement evaluation at 60 degrees will be assessed with the HUMAC NORM device

Fasting HbA1c levels1 day

Measure fasting HbA1c levels

Fasting insulin levels1 day

Measure fasting insulin levels

Fasting cholesterol levels1 day

Measure fasting cholesterol levels

Fasting triglycerides levels1 day

Measure fasting triglycerides levels

Fasting glucose levels1 day

Measure fasting glucose levels

Secondary Outcome Measures
NameTimeMethod
Changes in isometric peak torque24 weeks

Measure the change in peak torque value generated during isometric knee extension/flexion movement evaluation at 60 degrees will be assessed with the HUMAC NORM device pre and post intervention

Changes in WHR24 weeks

Measure changes in WHR during intervention

Changes in isokinetic peak torque24 weeks

Measure the change in peak torque value generated during isokinetic knee extension/flexion movement evaluation at 60 degrees will be assessed with the HUMAC NORM device pre and post intervention.

Body circumference from 2D imaging24 weeks

A conventional digital camera will be used to capture 2D images of participants in a standardized pose. Body circumference will be estimated using these images.

Systolic and Diastolic blood pressure levels will be assessed24 weeks

Manually measure systolic and diastolic blood pressure levels.

Changes in lean mass24 weeks

Measure changes in lean mass (arms, legs, trunk, and total) during intervention using DXA data.

Changes in automatic 3DO scan measurement24 weeks

Changes of automated 3DO measurements during intervention

Fat loss24 weeks

Measure changes in fat mass during intervention using DXA data.

Total Body Water24 weeks

Measure total body water (L) provided by bioelectrical impedance analysis

Diet History Questionnaire II24 weeks

The Diet History Questionnaire II estimates the participants nutrition intake by asking the participant a series of questions

Phase angle24 weeks

Phase angle \[PhA(°) = (reactance/electrical resistance) × (180°/Π)\] will be measured in degrees using bioelectrical impedance analysis.

Percent body fat24 weeks

Measure percent body fat provided by bioelectrical impedance analysis.

Trial Locations

Locations (3)

Pennington Biomedical Research Center

🇺🇸

Baton Rouge, Louisiana, United States

University of Hawaii Cancer Center

🇺🇸

Honolulu, Hawaii, United States

University of California, San Francisco

🇺🇸

San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath